Medical Mycology

Article	Citations
Development of in-house ELISA for Scedosporium/Lomentospora serodiagnosis	78
P422 EQUAL PCP Score 2022—an ECMM score derived from current guidelines to measure QUAlity of clinical Pneumocystis Pneumonia management	68
S5.1b Antifungal r esistance	57
P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India	46
Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants	46
P373 Does biofilm forming capacity of Candida tropicalis vary with echinocandin susceptibility?	45
P216 Rare isolates from subcutaneous mycotic lesions; A study from tertiary care center in Chhattisgarh, India	44
S2.2d Evaluation of new tools for the diagnosis of histoplasmosis	44
P196 A rare presentation of subcutaneous Entomophthoramycosis	42
P361 Demystifying the NIH grant application process for international investigators	41
P335 Genome plasticity in Candida albicans : acutting-edge strategy for evolution, adaptation, and survival	40
S6.5c MycetOS: identifying drugs which can penetrate the mycetoma grain	36
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis	31
P020 Risk factors, speciation ,and antifungal susceptibility in candidemia patients: An observational study	30
S1.3c Diversity and hybridization in Malassezia furfur	30
P019 A 5-year study on prevalence and molecular determinants of fluconazole -resistance in C. parapsilosis spp. complex	26
Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis	26
Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa	26
Superficial fungal infections in the south of France—is fusariosis the next emergent onychopathy?	24
Novel in vivo observations of luliconazole 5% nail solution for onychomycosis: An ultrastructural study	24
Clinical characteristics and outcomes of pancreatic fungal infection in patients with necrotizing pancreatitis	24
Knowledge and regulation on fungal contamination of sand and water: Progress report and perspectives	23
Fungal diagnostics capacity in Malaysia: A survey across 48 laboratories	22
Landscape of in situ cytokine expression, soluble C-type lectin receptors, and vitamin D in patients with recurrent vulvovaginal candidiasis	21
The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo	21

Invasive fungal infections in patients with haematological malignancies at the University Hospital of Reunion Island (2018–2022): An observational study	19
Ocular adnexal sporotrichosis: Case series from a hyperendemic region in southern Brazil	19
Clinical performance of the fully automated quantitative LeaDEA Pneumocystis PCR Kit for the diagnosis of Pneumocystis jirovecii	18
A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole	18
Prevalence of azole-resistant Aspergillus fumigatus and other aspergilli in the environment from Argentina	18
A 40-year antifungal susceptibility surveillance of Talaromyces marneffei (1984–2024) at a tertiary hospital in Guangxi, China	17
HAC1 contributes to stress adaptation and virulence in the emerging fungal pathogen Candida auris	17
P088 Molecular identification and antifungal susceptibility of pathogenic yeasts from the China Antifungal Resistance Surveillance Trial (CARST-fungi) Study	16
Evaluation of the drug–drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort	16
P466 Isolation of Cryptococcus neoformans and other yeast from pigeon droppings in Khartoum state, Sudan	16
P348 tRNA modifications in Candida virulence	16
P478 Identification of clinical Candida isolates using maldi-tof-ms and their antifungal susceptibility profile—a study from tertiary care pediatric hospital in noida	16
S8.3d Characterization of glycosylphosphatidylinositol-linked aspartyl proteases in Candida glabrata: Role in pathogenicity	15
P192 Investigating the link between pleomorphism and virulence in Cryptococcus	15
S3.4e Unraveling the role of DOG genes in a novel alternative pathway of glycerol biosynthesis in Candida albicans and its influence on virulence	15
S2.2a African histoplasmosis	15
P212 Fatal invasive aspergillosis in a child with Chronic Granulomatous disease; a case report	15
P382 Scalp fungal microbiome and sebum composition in males with and without androgenetic alopecia	14
S1.3d The human pathobiont Malassezia furfur secreted protease MfSAP1 regulates cell dispersal and exacerbates skin inflammation	14
S10.4c Successful treatment of mucormycosis in hematological diseases	14
P086 Clinical outcome and in vitro antifungal susceptibility of clinical isolates of rhino-orbito-cerebral mycosis associated with post COVID 19 from North India	14
S10.5c Insight into the role of secondary metabolism in the pathogenesis of Scedosporium apiospermum	14
P148 Emerging and cryptic Aspergillus species isolated from hospitalized patients with underlying primary immunodeficiencies	14
P355 Pitfalls in medical mycology in India	13
P344 Automatic detection of pneumocystis jirovecii in microscope images: adeep learning-based approach	13
P309 Clonal outbreak of Trichophyton tonsurans causing tinea capitis among wrestlers in Beijing, China	13
Effects of the novel mitochondrial targeted compound phosundoxin against Sporothrix globosa : Microbial sensitivity test combined with transcriptomics an	12
S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surger	12
Antibodies against Histoplasma capsulatum and Aspergillus fumigatus among chronic TB patients in Indonesia: a cross-sectional study	12
P094 Atypical cutaneous manifestations of sporotrichosis in Brazil	12
Predicting intracranial involvement: Unveiling perineural spread in COVID-19-associated mucormycosis, a novel phenomenon	12
S9.5d Genotyping of Malassezia species from seborrheic dermatitis/dandruff patients	12
S5.5d SARS-CoV-2 associated invasive fungal sinus infections; the Sri Lankan perspective	12
Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance	12
S5.1d Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis	11
Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens Lis	11
P183 Monitoring of candida colonization in the respiratory tract of COVID-19 cases	11
P303 An unusual case of isolated gluteal abscess	11
Identification and antifungal susceptibility profile of uncommon yeast species at Fattouma Bourguiba University Hospital in Tunisia	11
Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia	11
P345 The relationship between virulence of Candida albicans and environmental oxygen concentration	11
Evaluation of the DermaGenius® Resistance Multiplex Real-Time PCR assay for rapid identification and detection of terbinafine resistant Trichophyton mentagrophytes	11
Antifungal efficacy of natural antiseptic products against Candida auris	11
Mycology laboratory diagnostic capacity for invasive fungal diseases in public hospitals in Vietnam	11
P114 Clinical and microbiological spectrum of dermatophytosis from a tertiary care institute	11
P411 Genus specific real-time PCR-a promising technique for rapid diagnosis of fungal keratitis	10
P225 Subcutaneous phaeohyphomycosis by Phaeoacremonium species in a renal transplant recipient	10
P193 Candidemia in coronavirus disease 2019 patients in a university hospital in Buenos Aires, Argentina	10
P291 Aspergillosis: another force to reckon with during COVID-19 times	10
Aspergillus sensitisation detection using point-of-care lateral flow assay in moderate to severe asthma	10

P113 Expression profile of ABC and MFS multi-drug transporter genes in terbinafine- and fluconazole-resistant Trichophyton spp.	10
P118 Pentraxin-3 interacts with Aspergillus fumigatus conidia to regulate pro-inflammatory cytokine production	9
Management of disseminated histoplasmosis in a high-complexity clinic in Cali, Colombia	9
Evaluation of direct antifungal susceptibility testing using E-test for four antifungal agents in candidemia patients	9
Lumbar puncture frequency and patient survival among persons hospitalized with cryptococcal meningitis in the United States	9
Opaque cell-specific proteome ofCandida albicansATCC 10231	9
P313 A retrospective analysis of COVID-19 - associated Mucormycosis in a tertiary care center in Northern India	9
S4.1d In vitro activity of eight antifungals against 3343 filamentous pathogenic fungi collected during 18 years at the French National Reference Center for invasive mycosis and antifungals	9
Evaluation of the PneumoGenius® PCR assay for the diagnosis ofPneumocystispneumonia and the detection ofPneumocystisdihydropteroate synthase mutations in respiratory samples	9
Whole genome characterization of Trichophyton indotineae isolated in Singapore	9
Cryptococcus gattii complex infections in southern Brazil: Epidemiology, clinical features, management, and outcomes from a 33-year cohort	9
Malassezia japonica isolated from the cerumen of Cercopithecidae and Hylobatidae	9
Detection and genotyping of zoonotic microsporidia in the endangered Iberian lynx (Lynx pardinus)	9
Predictors of mortality in individuals with disseminated histoplasmosis and advanced HIV disease	9
P420 Fungal detection by means of HCR using 2D-Covalent Organic Framework Nanosheet	9
Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortality	9
P435 Evaluation of remote triazole capillary blood testing to facilitate remote therapeutic drug monitoring (TDM): A validation study	8
P131 Optimization of MTT assay protocol in Pythium insidiosum zoospores incubated together with neutrophils	8
Evaluation of a commercial Histoplasma antigen detection enzyme immunoassay for the follow-up of histoplasmosis treatment in people living with HIV from Argentina	8
S9.5c Malassezia-host interactions and the Il-23/17 axis	8
A practical approach to investigating nosocomial acquisition of Aspergillus	8
Diagnostic accuracy of a novel lateral flow assay for histoplasmosis	8
S6.3d Candida albicans commensalism in the oral mucosa is favored by limited virulence and metabolic adaptation	8
P256 A rare case of co-infection with Nigrospora oryzae with mucormycosis in an immunocompromised post-COVID patient	8
P166 Traumatic implantation keratitis with Schizophyllum commune in Central India	8
S3.5a Contamination in sand and water of sea, lakes, and river beaches: Risk factor for fungal human disease	8
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility	8
Spectrum of clinically significant melanized fungi in NIH hospitalized patients and their antifungal susceptibility profiles	8
P018 Susceptibility profile of Candida albicans causing bloodstream infections against azole antifungals over 5 years: A prospective observational study	8
S8.1b Is a search and destroy strategy still feasible for Candida auris in South Africa?	8
S5.4d Agrochemicals potentiate multidrug resistance and alter virulence in Cryptococcus neoformans via hitch-hiking effect of aneuploidy	8
Evaluation of interleukin-8 levels in the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies	8
S2.4d Combination antifungal effects of eugenol with voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares	8
Performance of Fungitell STAT point-of-care test for the diagnosis of invasive fungal diseases	8
Molecular typing and antifungal susceptibility of clinical isolates of Cryptococcus neoformans and Cryptococcus gattii species complexes from the National Invasive Fungal Surveillance Ne	7
Zoonotic Enterocytozoon bieneusi genotypes in free-ranging and farmed wild ungulates in Spain	7
P110 AIRE gene mutation predisposing chronic mucocutaneous Candidiasis in two kids from a Chinese family	7
S7.4a Vaccine-inducing lung resident CD4 + memory T cells are protective against Cryptococcus gattii infections	7
P372 Deciphering transcript isoform switching and utilization in mature biofilm of Candida glabrata through a global transcriptomic approach	7
Clinical and imaging characteristics of pulmonary cryptococcosis: a comparative analysis of 118 non-AIDS patients in China	7
Copper-only Superoxide dismutase 6 contributes to reactive oxygen species regulation, genotoxic stress tolerance, and virulence in Candida albicans	7
P317 Phaeohyphomycosis caused by Phialophora verrucosa in a patient with CARD9 mutations	7
P233 COVID-19-a ssociated Mucormycosis: an experience of invasive fungal sinusitis from a tertiary care referral center in Northern India	7
P414 Diagnostic allele-specific PCR for the identification of Candida auris clades and common resistance mutations	7
Comparison of three culture media for testing susceptibility of Malassezia pachydermatis to four antifungal agents by a microdilution method and gradient	7
Dual quantitative PCR assays for the rapid detection of Trichophyton indotineae from clinical samples	7
P438 Epidemiology, risk factor analysis and management of invasive Candida auris infections in tertiary care hepatobiliary center in India	7
P334 Fungal infections in patients with COVID-19 in 1-year pandemic 2020-2021 from Cote d'Ivoire	7
P206 Phenotypic and molecular characterization of emerging Basidiomycete Schizophyllum commune isolated from clinical samples from India	6
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis–a two-centre observational study	6
P501 Aspergillus fumigatus complicates one third of the patients with suspected bronchial asthma or pulmonary tuberculosis: Clinical validation of indigenously developed diagnostic kits	6
The incidence, duration, and risk factors for diagnostic delays associated with blastomycosis	6
Coccidioidesspp. exposure among military working dogs in endemic regions of the United States	6
Molecular detection of Enterocytozoon bieneusi in bats from Portugal	6
Evaluation of an in-house pan-Malassezia quantitative PCR in human clinical samples	6
P273 Diagnostic dilemmas in Pneumocystis pneumonia in case of long COVID -19	6
P223 First case of Candida auris candidemia in Manipur, Northeast India	6
A diverse spectrum of mycoses histologically diagnosed in Ghana: Insights from a 10-year retrospective study	6
Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study	6
Mucorales: A systematic review to inform the World Health Organization priority list of fungal pathogens	6
P502 Mycology lab of the future—slants to sequencing	6
P299 A clinicomycological study of suspected mucormycosis in post-COVID patients attending a tertiary care hospital	6
P391 Research on molecular diagnostic methods and clinical application of common pathogenic dermatophytes in tinea capitis	6
P486 Disseminated Cryptococcosis diagnosed on fine needle aspiration cytology	6
P364 Quantitative monitoring of Aspergillus fumigatus mycelial growth by optical density	6
P068 Inhibition of Candida glabrata biofilm using the combination of a novel antifungal cyclic lipopeptide and azole: An in vitro synergistic approach	6
P432 Detection of erg11 gene mutation in fluconazole resistant Candida albicans isolates	6
S1.5d Spectrum of etiological agents of mycotic keratitis: A n 11- year review	5
Epidemiological shifts of invasive fungal infections in the current era of haematology	5
Exploring virulence attributes in non-Cryptococcus Tremellomycetes	5
A notable azole-nonsusceptible Candida orthopsilosis in the Candida parapsilosis complex isolated from onychomycosis in Hue City, Central Vietnam	5
Investigation of invasive fungal infection in tuberculosis/human immunodeficiency virus co-infected patients	5
S6.2d Dermatophytosis due to Trichophyton erinacei caused by contact with African hedgehogs as family pets	5
Closing the diagnostic gap in medical mycology: The LODDY Test for identification of Lodderomyces elongisporus	5
The in vitro activity of iron chelator deferiprone against Candida (Candidozyma) auris in combination with	5
Aspergillus fumigatus—a systematic review to inform the World Health Organization priority list of fungal pathogens	5
Vaginal homeostasis features of Vulvovaginal Candidiasis through vaginal metabolic profiling	5
P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study	5
Deep learning for the identification of Candida spp. directly from blood culture gram stains from candidemia patients	5
P294 A descriptive study of Trichosporon fungemia cases from tertiary care center from north India	5

Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis	5
Exposure to itraconazole influences the susceptibility to antifungals, physiology, and virulence of Trichophyton interdigitale	5
P135 Immunological correlation with clinicomycological aspects of fungal rhinosinusitis during COVID-19 pandemic	5
Post-COVID-19 rhino-orbito-cerebral mucormycosis—A clinico-mycological study from North India	5
P171 Pneumocystis Jirovecii Pneumonia in non-HIV immunosuppressed patients: Acase series	5
P328 An overexpression screen identifies Csa25 as a novel cellular morphogenesis regulator in the human fungal pathogen Candida albicans	5
Protoellisomyces batrachophilus , gen. et sp. nov., a novel member of the Mucor circinelloides complex causing mucormycosis in	5
Candidemia during the COVID-19 pandemic in a Brazilian tertiary care hospital: comparison of episodes with and without COVID-19	5
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022	5
P211 Fungal and bacterial co-infections of the respiratory tract among patients with COVID-19 hospitalized in intensive care units	5
P057 All- cause mortality in patients with invasive Candidiasis or candidemia from an interim analysis of a Phase 3 Open-label Study (FURI)	5
Cryptococcosis in domestic and wild animals: A review	5
Routine laboratory screening for cyp51a-related azole resistance in Aspergillus fumigatus using Etest: Concordance with gene sequencing	5
Value of qPCR in the screening strategy for Candida auris	5
Mortality patterns in candidemia: Insights from a multispecies analysis using a global research network	5
P032 Efficacy of novel azole compounds (ATTAF-1 and ATTAF-2) against Candida albicans in a murine model of invasive Candidiasis	5
KL-6 as a predictor of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) and mortality in critically ill COVID-19 patients: A single-center retrospective cohort study	5
High histoplasmosis incidence in kidney transplant recipients in Santa Fe city, Argentina	5
Octyl gallate as a treatment for Candida albicans-induced vaginal infection: Effects on fungal burden, inflammation, and Lactobacillus recovery in mice	5
Identification of potential targets in bone destruction by Talaromyces marneffei: Insights from data-independent acquisition proteomics	5
Epidemiology of candidemia during COVID-19 pandemic era in a teaching hospital: A non-concurrent cohort study	5
S9.1d Chronic pulmonary aspergillosis in post-TB and retreatment TB patients in Lagos, Nigeria	5
P078 Baseline antifungal usage patterns and knowledge regarding management of invasive fungal infections as a part of a multidisciplinary antifungal stewardship (AFS) program	5
Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature	4
Cross-reactivity of cryptococcal antigen lateral flow assay with basidiomycetous yeasts	4
Effectiveness of diphenyl diselenide against experimental sporotrichosis caused by Sporothrix brasiliensis	4
Metabolic and morphostructural plasticity of environmental and animal strains of Nannizzia gypsea	4
P075 Initial results of an international effort in screening new agents against Candida auris	4
Interference of Malassezia restricta in the invasion of Staphylococcus aureus into human keratinocytes	4
P458 Comparison of PCR protocols for detecting Histoplasma capsulatum and Coccidioides spp. DNA through a multicenter study	4
P217 Pelvic mycoses— an unusual presentation of Rhizopus arrhizus in an ommunocompetent patient	4
P383 ‘It's not Fungus, its Nocardia’—an elementary diagnostic challenge for draining sinus on abdominal wall (rare): a case report	4
P337 Species distribution and biofilm profile of Candida isolated from clinical specimens at a tertiary care hospital in India	4
The Billirud Mill Blastomycosis Outbreak: Comparison to Historical Controls	4
P041 Preliminary evaluation of gradient concentration strips for detection of terbinafine resistance in Trichophyton spp.	4
P484 Expanding VGVI—evidence for distinct Cryptococcus gattii (decagattii) endemic to the American Southwest	4
Evaluation of simple molecular methods for distinction of the newly emerging dermatophyte Trichophyton indotineae	4
Malassezia gallinae sp. nov., a new basidiomycetous yeast species isolated from skins of chickens	4
A Falciformispora senegalensis grain model in Galleria mellonella larvae	4
S9.4c Diverse environmental inputs mediate changes in β-glucan exposure at the Candida albicans cell surface thereby influencing tissue colonisation during systemic infection	4
P417 Evaluation of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)-Bruker Biotyper Sirius for identification of invasive molds	4
P269 Managing prosthetic valve endocarditis due to Sarocladium kiliense: Finding a way through uncertainties	4
P371 The relation of mating type (MAT) preference and source in the opportunistic pathogen Talaromyces marneffei	4
P395 Clinical utility of semi-nested conventional PCR for diagnosis of mucormycosis in fresh clinical samples	4
The Argentinian landscape of mycological diagnostic capacity and treatment accessibility	4
S6.2b In vitro susceptibility testing of dermatophytes: toward standardization	4
Talaromyces marneffei, Coccidioides species, and Paracoccidioides species—a systematic review to inform the World Health Organization priority list of fungal pathogens	4
Natural history of pulmonary coccidioidomycosis: Further examination of the VA-Armed Forces Database	4
Perspective on receptor-associated immune response to Candida albicans single and mixed infections: Implications for therapeutics in oropharyngeal candidiasis	4
P326 DNA replication initiator proteins stabilize the kinetochore in the human fungal pathogen Cryptococcus neoformans	4
Occupational non-invasive aspergillosis: a national multicenter retrospective study from the French National Network for Occupational and Environmental Disease Monitoring and Prevention (RNV3PE) 2001–	4
S1.4d Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with cryptococcosis	4
S10.5a Fungal respiratory infections in cystic fibrosis patients in the Middle East	4
P154 Fungal spore count in a tertiary care hospital in Mumbai, India	4
P370 Low rate of Sporothrix spp. recovery from storage in mineral oil: along period study	4
P251 Disseminated Histoplasmosis in a Ghanaian HIV Patient: Role of Urine Histoplasma Antigen Testing in Rapid Diagnosis	4
P213 Lasiodiplodia theobromae: an emerging human pathogen	4
P204 Secondary organizing pneumonia caused by Aspergillus flavus in immunocompromised patients	3
Evidence of anti-Hcp100 antibodies in COVID-19 critically ill patients with detectable anti-histoplasmin antibodies in a highly endemic area for histoplasmosis	3
P442 Bacterial and fungal infection in COVID-19 diagnosed cases in a tertiary care ICU setting in the wake of second wave in Kolkata, India	3
P468 Aspergillosis in a colony of Humboldt penguins (Spheniscus humboldti) under managed care: a clinical and environmental investigation in a French zoological park	3
P138 A decade of cat-transmitted sporotrichosis (CTS) in a tertiary hospital from Curitiba, southern Brazil (2011-21)	3
Molecular detection and species identification of dermatophytes by SYBR-Green real-time PCR in-house methodology using hair samples obtained from dogs and cats	3
P098 Human protothecosis: Acase report in Northeastern Brazil	3
High prevalence of central nervous system cryptococcosis using a fingerprick whole-blood lateral flow assay in individuals with neurological symptoms and advanced HIV disease in a Brazilian emergency	3
P367 Candida sepsis in neonates a neglected pathogen: study from neonatal intensive care unit tertiary care hospital	3
The need for fast and accurate detection of dermatomycosis	3
Correction to: Candida albicans—A systematic review to inform the World Health Organization Fungal Priority Pathogens List	3
Histoplasmaantigens as novel players for the development of new enzyme immunoassays for the serodiagnosis of histoplasmosis: A comparative study of their analytical performance	3
P176 Basidiobolus meristosporus — anew species on the block!	3
Insights into LysM proteins of medically important yeasts	3
P178 An unusual recurrent case of Cryptococcal sacroilitis in an immunocompetent elderly female in Rajasthan, India	3
P174 Prevalence and outcomes of patients with COVID - associated mucormycosis (CAM): A case series	3
S8.3b How fungal cell wall glycans modulate the activation of platelets ?	3
P338 Clinicopathologic analysis of COVID-19-associated mucormycosis-experience from a tertiary care center in north india	3
P259 Rare presentations of Cryptococcosis: a case series	3
S1.5b The burden of mycotic keratitis in West Africa	3
S3.4d The role of NLRP3 inflammasome in host defense during Talaromyces marneffei infection	3
Clinical utility of pharmacogenomic testing for patients with coccidioidal meningitis	3
International Society for Human and Animal Mycology (ISHAM) One Health Sporotrichosis Working Group Proceedings—Bogota, Colombia, 2024 INFOCUS Conference	3
P351 Genetic recombination between the main human skin commensal fungus, Malassezia restricta, and M. globosa using an Agrobacterium tumefaciens-mediated gene transfer system	3
Comparison of coccidioidal complement fixation and quantitative immunodiffusion serology at a reference laboratory	3
S6.4c Primary cutaneous implantation coccidioidomycosis	3
S8.2a Trends in epidemiology of pediatric Candida infections	3
P054 Two effects of curcumin to Candida albicans	3
P320 Ten cases of tinea incognito due to Trichophyton rubrum, and literature review on the pathogenic characteristics	3
P426 Interleukins—a non-invasive biomarker for invasive fungal sinusitis	3
S8.3c Cell wall glycans as targets for the development of new antifungals	3
S4.3b Candida glabrata-host interactions	3
P388 High rate of chronic pulmonary aspergillosis in active TB patients in Indonesia with GeneXpert positive	3
P242 Autochthonous cases of Madura foot from Jodhpur, Western Rajasthan, India	3
P124 Cryptococcus neoformans-and Cryptococcus gattii-specific antibodies vary among children and adults with cryptococcosis and healthy from Colombia	3
Geraniol inhibits both planktonic cells and biofilms of the Candida parapsilosis species complex: Highlight for the improved efficacy of amphotericin B, caspofungin and fluconazole plus Geranio	3
Detection of pan-azole resistant Aspergillus fumigatus in horticulture and a composting facility in Belgium	3
Invasive aspergillosis caused by cryptic species in transplant recipients: A review	3